Home2VF0 • FRA
add
Hemostemix Inc
Previous close
€0.052
Day range
€0.060 - €0.060
Year range
€0.019 - €0.36
Market cap
22.04M CAD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.03M | 216.22% |
Net income | -1.28M | -170.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.03M | -216.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 965.16K | 2,652.19% |
Total assets | 1.23M | 1,201.79% |
Total liabilities | 8.69M | 9.53% |
Total equity | -7.47M | — |
Shares outstanding | 145.31M | — |
Price to book | -1.04 | — |
Return on assets | -231.48% | — |
Return on capital | 101.99% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -1.28M | -170.13% |
Cash from operations | 337.47K | 380.41% |
Cash from investing | -145.58K | — |
Cash from financing | 67.58K | — |
Net change in cash | 259.46K | 315.60% |
Free cash flow | 711.53K | 947.80% |
About
Headquarters
Website
